Immunohematology Market Growth Forecast Through 2030: Market Size And Trends In 2026
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Immunohematology Market Forecast: What Value Will The Market Reach By 2030?
The immunohematology market has witnessed consistent expansion in recent years. It is projected to increase from $2.56 billion in 2025 to $2.69 billion in 2026, showing a compound annual growth rate (CAGR) of 4.9%. This growth in previous periods is attributable to the rising occurrence of blood disorders, an elevated demand for safe blood transfusions, the establishment of blood banks, the expansion of diagnostic laboratories, and progress in hematology reagents.
The immunohematology market is anticipated to show significant expansion in the coming years. It is projected to achieve a value of $3.27 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. This forecasted growth can be attributed to several factors including technological progress in analyzers, the integration of AI into laboratory diagnostics, the rise of precision medicine, the adoption of digital health systems, and the broadening of blood screening initiatives. Noteworthy trends expected during this period involve advanced methods for blood typing, increased automation in immunohematology testing, personalized transfusion strategies, point-of-care immune diagnostic tools, and the integration of laboratory information systems.
Get A Free Sample Report With In-Depth Market Insights:
Immunohematology Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The immunohematology market is projected to experience growth driven by the aging population, which describes a demographic trend where the proportion of elderly individuals within a society increases. Immunohematology is crucial for managing age-related transfusion requirements, ensuring the safe use of blood products, and supporting medical interventions for this demographic. As an illustration, in January 2024, the US-based nonprofit organization Population Reference Bureau indicated that the number of Americans aged 65 and older is expected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Concurrently, this group’s share of the overall population is also foreseen to rise from 17% to 23% during the same period. Thus, the aging population is a primary force propelling the expansion of the immunohematology market.
Immunohematology Market Segment Breakdown: Which Categories Lead On Revenue?
The immunohematology market covered in this report is segmented –
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum
Immunohematology Market Innovation Trends Shaping Future Development
Companies active in the immunohematology market are focused on developing innovative diagnostic solutions, such as soluble recombinant proteins, designed to overcome interference from the cancer therapy daratumumab. A soluble recombinant protein is one produced through recombinant DNA technology that remains properly folded and functional in a soluble form within a host cell or solution, making it useful in research and therapeutic applications. For example, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched the Grifols sCD38 solution. Grifols’ sCD38 is the first-ever soluble recombinant protein, developed to address the interference caused by the cancer therapy daratumumab in vital blood transfusion compatibility testing. Specifically designed for multiple myeloma patients, this groundbreaking solution blocks daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise pre-transfusion test outcomes. By facilitating a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in delivering lifesaving transfusions.
Immunohematology Market Leading Players And Competitive Positioning
Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.
View The Full Immunohematology Market Report:
Immunohematology Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
